Benign tumors from the human nervous system express high levels of survivin and are resistant to spontaneous and radiation-induced apoptosis

被引:22
作者
Hassounah, M
Lach, B
Allam, A
Al-Khalaf, H
Siddiqui, Y
Pangue-Cruz, N
Al-Omeir, A
Al-Ahdal, M
Aboussekhra, A
机构
[1] King Faisal Specialist Hosp & Res Ctr, BMR, Dept Biol & Med Res, Riyadh 11211, Saudi Arabia
[2] King Faisal Specialist Hosp & Res Ctr, Dept Neurosci, Riyadh 11211, Saudi Arabia
[3] King Faisal Specialist Hosp & Res Ctr, Dept Pathol, Riyadh 11211, Saudi Arabia
[4] King Faisal Specialist Hosp & Res Ctr, Dept Radiat Oncol, Riyadh 11211, Saudi Arabia
[5] King Faisal Specialist Hosp & Res Ctr, Dept Comparat Med, Riyadh 11211, Saudi Arabia
关键词
apoptosis; benign tumors; gamma-rays; nervous system; survivin; UV light;
D O I
10.1007/s11060-004-2397-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Survivin, an inhibitor of apoptosis, is over-expressed in foetal tissues and human cancers, but it is almost undetectable in normal tissues. Here we have assessed the level of the survivin protein in some benign tumors of the nervous system: meningioma, schwannoma, low-grade ependymoma, pilocytic astrocytoma and pituitary adenoma. Using immuno-blot analysis we present evidence that these low-grade tumors are positive for survivin expression. In agreement, flow cytometrical analysis showed that both spontaneous and radiation-induced apoptosis levels are very low in these neoplasms. Using host cell reactivation assay we have also shown that these tumor cells are proficient in the repair of gamma-ray-induced DNA damage. However, they are deficient in the removal of ultraviolet (UV) light-induced DNA photolesions, especially the shwannoma- and the pituitary adenoma-derived cells. These results suggest that survivin overexpression may be an early event in the stepwise tumoregenesis and hence could be responsible for the onset as well as the growth advantage during tumoregenic progression of malignant as well as benign neoplasms.
引用
收藏
页码:203 / 208
页数:6
相关论文
共 20 条
[1]   HOST-CELL REACTIVATION OF ULTRAVIOLET-IRRADIATED SV40-DNA IN 5 COMPLEMENTATION GROUPS OF XERODERMA PIGMENTOSUM [J].
ABRAHAMS, PJ ;
VANDEREB, AJ .
MUTATION RESEARCH, 1976, 35 (01) :13-22
[2]   Validating survivin as a cancer therapeutic target [J].
Altieri, DC .
NATURE REVIEWS CANCER, 2003, 3 (01) :46-54
[3]   Survivin, versatile modulation of cell division and apoptosis in cancer [J].
Altieri, DC .
ONCOGENE, 2003, 22 (53) :8581-8589
[4]   A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma [J].
Ambrosini, G ;
Adida, C ;
Altieri, DC .
NATURE MEDICINE, 1997, 3 (08) :917-921
[5]   Regulation of p53 downstream genes [J].
El-Deiry, WS .
SEMINARS IN CANCER BIOLOGY, 1998, 8 (05) :345-357
[6]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[7]   Inhibition of melanoma tumor growth in vivo by survivin targeting [J].
Grossman, D ;
Kim, PJ ;
Schechner, JS ;
Altieri, DC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (02) :635-640
[8]   Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53 [J].
Grossman, D ;
Kim, PJ ;
Blanc-Brude, OP ;
Brash, DE ;
Tognin, S ;
Marchisio, PC ;
Altieri, DC .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (07) :991-999
[9]   Brain and other central nervous system tumors: rates, trends, and epidemiology [J].
Gurney, JG ;
Kadan-Lottick, N .
CURRENT OPINION IN ONCOLOGY, 2001, 13 (03) :160-166
[10]   The hallmarks of cancer [J].
Hanahan, D ;
Weinberg, RA .
CELL, 2000, 100 (01) :57-70